On the analysis and interpretation of outcome measures in stroke clinical trials: Lessons from the SAINT I study of NXY-059 for acute ischemic stroke

Stroke

Volumn 37, Issue 10, 2006, Pages 2644-2647

  Koziol, James A ^a   Feng, Anne C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Mann Whitney statistics; Numbers needed to treat or harm

Indexed keywords

DISUFENTON SODIUM; PLACEBO;

ANALYTIC METHOD; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANK SUM TEST; RANKIN SCALE; RATING SCALE; REVIEW; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; BENZENESULFONATES; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CARDIOVASCULAR AGENTS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CLINICAL TRIALS, PHASE III; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FREE RADICAL SCAVENGERS; HUMANS; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; NITROGEN OXIDES; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33749001683     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000241106.81293.2b     Document Type: Review

References (21)

1. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. New Engl J Med. 2006;354:588-600.
2. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
3. Moses LE, Emerson JD, Hosseini H. Analyzing data from ordered categories. New Engl J Med. 1984;311:442-448.
4. Acion L, Peterson JJ, Temple S, Arndt S. Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Statist Med. 2006;25:591-602.
5. Newcombe RG. Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 1: General issues and tail-area-based methods. Statist Med. 2006;25:543-557.
6. Newcombe RG. Confidence intervals for the effect size measure based on the Mann-Whitney statistic. Part 2: Asymptotic methods and evaluation. Statist Med. 2006;25:559-573.
7. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall, New York, 1993.
8. Cook RJ, Sackett DL. The number needed to treat: a clinically useful; measure of treatment effect. Brit J Med. 1995;310:452-454.
9. Altman DG. Confidence intervals for the number needed to treat. Brit J Med. 1998;317:1309-1312.
10. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Arch Neurol. 2004;61:1066-1070.
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences, Revised Edition. New York: Academic Press; 1977.
12. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care. 2003;5:582-592.
13. Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Statist. 2004;14:73-96.
14. Del Zoppo GJ. Stroke and neurovascular protection. New Engl J Med. 2006;354:553-555.
15. Dromerick AW, Edwards DF, Diringer MN. Sensitivity to changes in disability after stroke: A comparison of four scales useful for clinical trials. J Rehabil Res Dev. 2003;40:1-8.
16. Young FB, Weir CJ, Lees KR. Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials. Stroke. 2005;36:2187-2192.
17. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med. 1995;333:1581-1587.
18. Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Lyden P, Grotta J. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke. 1996;27:2136-2142.
19. Streiner D, Norman G. Health Measurement Scales: A Practical Guide to Their Development and Use, 3rd ed. New York: Oxford University Press; 2003.
20. New PW, Buchbinder R. Critical appraisal and review of the Rankin scale and its derivatives. Neuroepidemiology. 2006;26:4-15.
21. Bruno A, Saha C, Williams LS. Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials. Stroke. 2006;37:920-921.